Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (221-230 of 600) with videos related to

Pageof 60
Sort By:
Rheumatology (Oxford, England)|August 13, 2021
Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA studyDafne Capelusnik, Sizheng Steven Zhao, Annelies Boonen, et al.
Arthritis Care & Research|June 11, 2010
Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristicsWalter P Maksymowych, Katherine Gooch, Maxime Dougados, et al.
Arthritis Research & Therapy|October 1, 2017
Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORAAntje van der Zee-Neuen, Polina Putrik, Sofia Ramiro, et al.
Arthritis and Rheumatism|June 2, 2006
Development of classification and response criteria for rheumatic diseasesJasvinder A Singh, Daniel H Solomon, Maxime Dougados, et al.
Seminars in Arthritis and Rheumatism|April 30, 2022
What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA studyNelly Ziade, Joe Rassi, Bassel Elzorkany, et al.
The Journal of Rheumatology|August 23, 2006
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritisJean-David Cohen, Maxime Dougados, Philippe Goupille, et al.
RMD Open|December 20, 2023
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohortImke Redeker, Robert Landewé, Désirée van der Heijde, et al.
Arthritis and Rheumatism|December 2, 2006
Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitisFlorence Tubach, Thao Pham, Johan F Skomsvoll, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Vitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international studySílvia Fernandes, Adrien Etcheto, Désirée van der Heijde, et al.
Arthritis Research & Therapy|November 28, 2014
Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE studyMaxime Dougados, Emily Wood, Bernard Combe, et al.
Pageof 60

Showing results (221-230 of 600) with videos related to

Sort By:
Pageof 60
Rheumatology (Oxford, England)|August 13, 2021
Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA studyDafne Capelusnik, Sizheng Steven Zhao, Annelies Boonen, et al.
Arthritis Care & Research|June 11, 2010
Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristicsWalter P Maksymowych, Katherine Gooch, Maxime Dougados, et al.
Arthritis Research & Therapy|October 1, 2017
Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORAAntje van der Zee-Neuen, Polina Putrik, Sofia Ramiro, et al.
Arthritis and Rheumatism|June 2, 2006
Development of classification and response criteria for rheumatic diseasesJasvinder A Singh, Daniel H Solomon, Maxime Dougados, et al.
Seminars in Arthritis and Rheumatism|April 30, 2022
What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA studyNelly Ziade, Joe Rassi, Bassel Elzorkany, et al.
The Journal of Rheumatology|August 23, 2006
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritisJean-David Cohen, Maxime Dougados, Philippe Goupille, et al.
RMD Open|December 20, 2023
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohortImke Redeker, Robert Landewé, Désirée van der Heijde, et al.
Arthritis and Rheumatism|December 2, 2006
Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitisFlorence Tubach, Thao Pham, Johan F Skomsvoll, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Vitamin D status in spondyloarthritis: results of the ASAS-COMOSPA international studySílvia Fernandes, Adrien Etcheto, Désirée van der Heijde, et al.
Arthritis Research & Therapy|November 28, 2014
Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE studyMaxime Dougados, Emily Wood, Bernard Combe, et al.
Pageof 60